Loading…
CIK 0001848809 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("velan-capital-investment-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4DMOLECULARTHERAPEUTICSIN | COM | $45K | 0.0% | 12,000 SH | New |
| ACLARISTHERAPEUTICSINC | COM | $46K | 0.0% | 32,700 SH | New |
| ALECTORINC | COM | $77K | 0.1% | 55,000 SH | New |
| ALUMISINC | COM | $4.9M | 4.8% | 1,620,846 SH | New |
| ARVINASINC | COM | $3.7M | 3.6% | 500,000 SH | New |
| AVALOTHERAPEUTICSINC | COMNEW | $773K | 0.8% | 154,972 SH | New |
| CIDARATHERAPEUTICSINC | COMNEW | $4.9M | 4.8% | 100,000 SH | New |
| CONTEXTTHERAPEUTICSINC | COM | $66K | 0.1% | 100,000 SH | New |
| CORBUSPHARMACEUTICALSHLDGS | COMNEW | $407K | 0.4% | 59,000 SH | New |
| CYTOMXTHERAPEUTICSINC | COM | $170K | 0.2% | 75,000 SH | New |
| DESIGNTHERAPEUTICSINC | COM | $67K | 0.1% | 20,000 SH | New |
| EDESABIOTECHINC | COMNEW | $1.4M | 1.4% | 687,500 SH | New |
| ELEDONPHARMACEUTICALSINC | COM | $919K | 0.9% | 338,973 SH | New |
| ERASCAINC | COM | $83K | 0.1% | 65,000 SH | New |
| GERONCORP | COM | $99K | 0.1% | 70,000 SH | New |
| GOSSAMERBIOINC | COM | $92K | 0.1% | 75,000 SH | New |
| HERONTHERAPEUTICSINC | COM | $14.5M | 14.3% | 6,986,744 SH | New |
| IMMIXBIOPHARMAINC | COM | $52K | 0.1% | 25,000 SH | New |
| INSPIREMDINC | COM | $2.1M | 2.0% | 904,029 SH | New |
| JASPERTHERAPEUTICSINC | COMNEW | $8.0M | 7.9% | 1,433,828 SH | New |
| KIORAPHARMACEUTICALSINC | COM | $352K | 0.3% | 122,223 SH | New |
| LARIMARTHERAPEUTICSINC | COM | $95K | 0.1% | 33,000 SH | New |
| LIQUIDIACORPORATION | COMNEW | $3.0M | 2.9% | 239,260 SH | New |
| MINERALYSTHERAPEUTICSINC | COM | $2.4M | 2.3% | 174,600 SH | New |
| NEKTARTHERAPEUTICS | CALL | $1.3M | 1.3% | 50,000 SH | New |
| NEXTCUREINC | COM | $21K | 0.0% | 45,000 SH | New |
| NURIXTHERAPEUTICSINC | COM | $114K | 0.1% | 10,000 SH | New |
| OVIDTHERAPEUTICSINC | COM | $53K | 0.1% | 160,000 SH | New |
| PERSPECTIVETHERAPEUTICSINC | COMNEW | $1.7M | 1.7% | 500,000 SH | New |
| PMVPHARMACEUTICALSINC | COM | $37K | 0.0% | 35,000 SH | New |
| PRAXISPRECISIONMEDICINESI | COMNEW | $6.3M | 6.2% | 149,334 SH | New |
| PROQRTHRAPEUTICSNV | SHSEURO | $92K | 0.1% | 45,000 SH | New |
| PROTAGONISTTHERAPEUTICSINC | COM | $204K | 0.2% | 3,700 SH | New |
| PROTARATHERAPEUTICSINC | COMSTK | $6.5M | 6.4% | 2,139,000 SH | New |
| PYXISONCOLOGYINC | COMMONSTOCK | $44K | 0.0% | 40,000 SH | New |
| REPLIMUNEGROUPINC | COM | $1.7M | 1.7% | 183,083 SH | New |
| REZOLUTEINC | COMNEW | $3.3M | 3.3% | 750,000 SH | New |
| SCPHARMACEUTICALSINC | COM | $3.5M | 3.5% | 917,668 SH | New |
| SUTROBIOPHARMAINC | COM | $2.2M | 2.2% | 3,060,000 SH | New |
| TELABIOINC | COM | $1.4M | 1.4% | 747,410 SH | New |
| TENAXTHERAPEUTICSINC | COMNEW | $480K | 0.5% | 83,333 SH | New |
| TERNSPHARMACEUTICALSINC | COM | $75K | 0.1% | 20,000 SH | New |
| TOURMALINEBIOINC | COM | $6.3M | 6.2% | 393,889 SH | New |
| UPSTREAMBIOINC | COM | $1.2M | 1.2% | 107,000 SH | New |
| VENTYXBIOSCIENCESINC | COM | $86K | 0.1% | 40,000 SH | New |
| VERONAPHARMAPLC | SPONSOREDADS | $9.0M | 8.9% | 95,000 SH | New |
| VIRIDIANTHERAPEUTICSINC | COM | $1.2M | 1.2% | 86,500 SH | New |
| VYNETHERAPEUTICSINC | COM | $50K | 0.0% | 30,000 SH | New |
| WAVELIFESCIENCESLTD | SHS | $98K | 0.1% | 15,000 SH | New |
| ZEVRATHERAPEUTICSINC | COMNEW | $6.3M | 6.2% | 715,000 SH | New |
| 13F-HR |
| 0001848809-26-000003 |
| $164.2M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001848809-25-000005 | $101.2M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001848809-26-000002 | $159.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000938552-25-000003 | $97.2M | View |